30 results
Page 2 of 2
10-KT
vwv21s8
26 Mar 18
Annual report (with FYE transition)
12:00am
8-K
EX-1.1
fbaq30st9eg20yf36
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-99.1
qvcs12f1itz sgl2
7 Jan 15
ContraVir Pharmaceuticals Granted FDA Meeting to Discuss Proposal for Phase 3 Trial of FV-100
12:00am
10-12G/A
EX-99.1
2faroga
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
z3nxvi t6yv
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
2azu8gjn
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
96ec6zmb0u x1u838y1j
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
im175qwyzfnceu7nge21
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-99.1
qjsrkogtl46i
8 Aug 13
Registration of securities
12:00am